The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 351:2129-2130 November 11, 2004 Number 20
NextNext

Venom Immunotherapy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Golden, D. B.K.
-PubMed Citation
To the Editor: Golden and colleagues (Aug. 12 issue)1 report on the long-term benefits of venom immunotherapy in children with moderate-to-severe systemic reactions to insect stings. The optimal method for administration of venom immunotherapy in children is not known. Ultra-rush immunotherapy2 offers potential advantages over standard or slow protocols, including the need for fewer injections and more rapid achievement of protection.

We performed a retrospective analysis of children who were sensitized to honeybee venom (mean [±SD] age, 9±3 years) and who had a history of moderate-to-severe systemic reactions after bee stings. The children received either slow bee-venom immunotherapy (18 children) . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.